Additional information
| Active substance | Glucagon-like Peptide-1 |
|---|---|
| Classification | Incretin Mimetics |
| Water Retention | Minimal |
| Hepatotoxicity | Low risk |
| Lab Test | Blood glucose levels, HbA1c |
| Also known as | N/A |
| Blood pressure | Can cause a reduction in blood pressure |
| Trade name | Ozempic, Rybelsus |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) |
| Chemical name | Semaglutide |
| Formula | C187H291N45O59 |
| Substance class | GLP-1 receptor agonist |
| Main action | Lowers blood glucose levels |
| Half-life | Approximately 1 week |
| Dosage (medical) | 0.25 mg once weekly, increasing to 0.5 mg and up to 1 mg as tolerated and needed |
| Dosage (sports) | Not recommended for use in sports |
| Effects | Improved glycemic control, weight loss |
| Side effects | Nausea, vomiting, diarrhea, abdominal pain, decreased appetite |
| Use in sports | None, not indicated for performance enhancement |
| Manufacturer | Beligas Pharmaceuticals |
Balkan Pharma Strombafort 10mg 100 Tabletten
Avory Pharma Deca Durabolin 300mg 10ml
Balkan Pharma Strombafort 50 mg 60 Tabletten
Aburaihan Oxabone 10 mg 30 Tabletten - Anavar
Kamagra Oral Jelly 100 mg 7 Beutel
Alpha Pharma Parabolin 76,5 mg 5 Ampere
Avory Pharma Oxymethelone 10mg 100 Kapseln
LACIPIL 4 mg Glaxosmithkline
Muscoflex 8 mg Bilim
Januvia 100mg Merckgroup
Kigtropin 100 IE Wachstumshormon
Genesis Meds Nandrolon Deca 250 mg 10 ml
AVELOX 400 Bayer
Clenbutaxyl Kalpa Pharmaceuticals
Letroxyl Kalpa Pharmaceuticals 

Reviews
There are no reviews yet.